Evidence map›Paper›PMID 35203726›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Genomic Analysis of ESBL-Producing

Timo Homeier-Bachmann, Anne K Schütz, Sylvia Dreyer, Julien Glanz, Katharina Schaufler, Franz J Conraths

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Prevalence and risk factors of antimicrobial resistance inOne health (Amsterdam, Netherlands) · 2026
    Article
  7. Article
  8. Antibiotic Resistance Profiles ofAntibiotics (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Multidrug-Resistant High-RiskAntibiotics (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Timo Homeier-BachmannFriedrich-Loeffler-Institut, Institute of Epidemiology, 17493 Greifswald-Insel Riems, Germany.ORCID 0000-0002-8135-3814
Anne K SchützFriedrich-Loeffler-Institut, Institute of Epidemiology, 17493 Greifswald-Insel Riems, Germany.ORCID 0000-0003-1964-8600
Sylvia DreyerFriedrich-Loeffler-Institut, Institute of International Animal Health/One Health, 17493 Greifswald-Insel Riems, Germany.ORCID 0000-0002-7403-9755
Julien GlanzFriedrich-Loeffler-Institut, Institute of Epidemiology, 17493 Greifswald-Insel Riems, Germany.
Katharina SchauflerInstitute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.ORCID 0000-0002-2669-8799
Franz J ConrathsFriedrich-Loeffler-Institut, Institute of Epidemiology, 17493 Greifswald-Insel Riems, Germany.ORCID 0000-0002-7400-9409
Friedrich-Loeffler-Institut · DEChristian-Albrechts-Universität zu Kiel · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a serious global health threat and extended-spectrum beta-lactamase (ESBL)-producing

Indexed as

AMRESBL-E. coliresistomewild boarwildlifewild ruminant

Identifiers

PMID35203726
PMCPMC8868512
OpenAlexW4206175817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.